Report Detail

Food & Beverages Global Bio Active Protein and Peptides Market Insights, Forecast to 2025

  • RnM3536238
  • |
  • 17 June, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Food & Beverages

Bio Active Protein and Peptides are peptide compounds that have beneficial or physiological effects on the life activities of living organisms. They are a class of peptides with a relative molecular mass of less than 6000 Da and various biological functions. Bioactive peptides have a variety of human metabolism and physiological regulation functions, easy to digest and absorb, and have the functions of promoting immunity, hormone regulation, antibacterial, antiviral, lowering blood pressure, lowering blood fat, etc.
Increasing health concerns and growing awareness of nutraceutical products among consumers are the primary factors expected to drive the global bio active protein and peptides market in the near future. Bio active protein and peptides display a number of physiological functionalities such as improving cardiovascular, nervous, gastrointestinal, and immune systems. A growing aging population and increasing incidence of chronic diseases among the people globally are other factors anticipated to drive revenue growth of the global bio active protein and peptides market. Also, a growing preference for bio active protein and peptides in cosmetics and personal care is likely to boost the global bio active protein and peptides market over the forecast period. However, stringent rules and regulations leading to increased operational costs and supply chain issues create a barrier for manufacturers operating in the global bio active protein and peptides market.
The global Bio Active Protein and Peptides market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bio Active Protein and Peptides market based on company, product type, end user and key regions.

This report studies the global market size of Bio Active Protein and Peptides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bio Active Protein and Peptides in these regions.
This research report categorizes the global Bio Active Protein and Peptides market by top players/brands, region, type and end user. This report also studies the global Bio Active Protein and Peptides market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Archer Daniels Midland Company
Kerry Group
Cargill
Omega Protein Corporation
Bunge
DuPont
Fonterra Co-operative Group
Royal DSM

Market size by Product
Plant Source
Animal Source
Market size by End User
Functional Food
Functional Beverages
Dietary Supplements
Animal Nutrition
Personal Care
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bio Active Protein and Peptides market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bio Active Protein and Peptides market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bio Active Protein and Peptides companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bio Active Protein and Peptides submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bio Active Protein and Peptides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio Active Protein and Peptides market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Bio Active Protein and Peptides Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Bio Active Protein and Peptides Market Size Growth Rate by Product
      • 1.4.2 Plant Source
      • 1.4.3 Animal Source
    • 1.5 Market by End User
      • 1.5.1 Global Bio Active Protein and Peptides Market Size Growth Rate by End User
      • 1.5.2 Functional Food
      • 1.5.3 Functional Beverages
      • 1.5.4 Dietary Supplements
      • 1.5.5 Animal Nutrition
      • 1.5.6 Personal Care
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Bio Active Protein and Peptides Market Size
      • 2.1.1 Global Bio Active Protein and Peptides Revenue 2014-2025
      • 2.1.2 Global Bio Active Protein and Peptides Sales 2014-2025
    • 2.2 Bio Active Protein and Peptides Growth Rate by Regions
      • 2.2.1 Global Bio Active Protein and Peptides Sales by Regions
      • 2.2.2 Global Bio Active Protein and Peptides Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Bio Active Protein and Peptides Sales by Manufacturers
      • 3.1.1 Bio Active Protein and Peptides Sales by Manufacturers
      • 3.1.2 Bio Active Protein and Peptides Sales Market Share by Manufacturers
      • 3.1.3 Global Bio Active Protein and Peptides Market Concentration Ratio (CR5 and HHI)
    • 3.2 Bio Active Protein and Peptides Revenue by Manufacturers
      • 3.2.1 Bio Active Protein and Peptides Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bio Active Protein and Peptides Revenue Share by Manufacturers (2014-2019)
    • 3.3 Bio Active Protein and Peptides Price by Manufacturers
    • 3.4 Bio Active Protein and Peptides Manufacturing Base Distribution, Product Types
      • 3.4.1 Bio Active Protein and Peptides Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Bio Active Protein and Peptides Product Type
      • 3.4.3 Date of International Manufacturers Enter into Bio Active Protein and Peptides Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Bio Active Protein and Peptides Sales by Product
    • 4.2 Global Bio Active Protein and Peptides Revenue by Product
    • 4.3 Bio Active Protein and Peptides Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Bio Active Protein and Peptides Breakdown Data by End User

    6 North America

    • 6.1 North America Bio Active Protein and Peptides by Countries
      • 6.1.1 North America Bio Active Protein and Peptides Sales by Countries
      • 6.1.2 North America Bio Active Protein and Peptides Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Bio Active Protein and Peptides by Product
    • 6.3 North America Bio Active Protein and Peptides by End User

    7 Europe

    • 7.1 Europe Bio Active Protein and Peptides by Countries
      • 7.1.1 Europe Bio Active Protein and Peptides Sales by Countries
      • 7.1.2 Europe Bio Active Protein and Peptides Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Bio Active Protein and Peptides by Product
    • 7.3 Europe Bio Active Protein and Peptides by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Bio Active Protein and Peptides by Countries
      • 8.1.1 Asia Pacific Bio Active Protein and Peptides Sales by Countries
      • 8.1.2 Asia Pacific Bio Active Protein and Peptides Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Bio Active Protein and Peptides by Product
    • 8.3 Asia Pacific Bio Active Protein and Peptides by End User

    9 Central & South America

    • 9.1 Central & South America Bio Active Protein and Peptides by Countries
      • 9.1.1 Central & South America Bio Active Protein and Peptides Sales by Countries
      • 9.1.2 Central & South America Bio Active Protein and Peptides Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Bio Active Protein and Peptides by Product
    • 9.3 Central & South America Bio Active Protein and Peptides by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Bio Active Protein and Peptides by Countries
      • 10.1.1 Middle East and Africa Bio Active Protein and Peptides Sales by Countries
      • 10.1.2 Middle East and Africa Bio Active Protein and Peptides Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Bio Active Protein and Peptides by Product
    • 10.3 Middle East and Africa Bio Active Protein and Peptides by End User

    11 Company Profiles

    • 11.1 Archer Daniels Midland Company
      • 11.1.1 Archer Daniels Midland Company Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Archer Daniels Midland Company Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Archer Daniels Midland Company Bio Active Protein and Peptides Products Offered
      • 11.1.5 Archer Daniels Midland Company Recent Development
    • 11.2 Kerry Group
      • 11.2.1 Kerry Group Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Kerry Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Kerry Group Bio Active Protein and Peptides Products Offered
      • 11.2.5 Kerry Group Recent Development
    • 11.3 Cargill
      • 11.3.1 Cargill Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cargill Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cargill Bio Active Protein and Peptides Products Offered
      • 11.3.5 Cargill Recent Development
    • 11.4 Omega Protein Corporation
      • 11.4.1 Omega Protein Corporation Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Omega Protein Corporation Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Omega Protein Corporation Bio Active Protein and Peptides Products Offered
      • 11.4.5 Omega Protein Corporation Recent Development
    • 11.5 Bunge
      • 11.5.1 Bunge Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bunge Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bunge Bio Active Protein and Peptides Products Offered
      • 11.5.5 Bunge Recent Development
    • 11.6 DuPont
      • 11.6.1 DuPont Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 DuPont Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 DuPont Bio Active Protein and Peptides Products Offered
      • 11.6.5 DuPont Recent Development
    • 11.7 Fonterra Co-operative Group
      • 11.7.1 Fonterra Co-operative Group Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Fonterra Co-operative Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Fonterra Co-operative Group Bio Active Protein and Peptides Products Offered
      • 11.7.5 Fonterra Co-operative Group Recent Development
    • 11.8 Royal DSM
      • 11.8.1 Royal DSM Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Royal DSM Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Royal DSM Bio Active Protein and Peptides Products Offered
      • 11.8.5 Royal DSM Recent Development

    12 Future Forecast

    • 12.1 Bio Active Protein and Peptides Market Forecast by Regions
      • 12.1.1 Global Bio Active Protein and Peptides Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Bio Active Protein and Peptides Revenue Forecast by Regions 2019-2025
    • 12.2 Bio Active Protein and Peptides Market Forecast by Product
      • 12.2.1 Global Bio Active Protein and Peptides Sales Forecast by Product 2019-2025
      • 12.2.2 Global Bio Active Protein and Peptides Revenue Forecast by Product 2019-2025
    • 12.3 Bio Active Protein and Peptides Market Forecast by End User
    • 12.4 North America Bio Active Protein and Peptides Forecast
    • 12.5 Europe Bio Active Protein and Peptides Forecast
    • 12.6 Asia Pacific Bio Active Protein and Peptides Forecast
    • 12.7 Central & South America Bio Active Protein and Peptides Forecast
    • 12.8 Middle East and Africa Bio Active Protein and Peptides Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Bio Active Protein and Peptides Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Bio Active Protein and Peptides . Industry analysis & Market Report on Bio Active Protein and Peptides is a syndicated market report, published as Global Bio Active Protein and Peptides Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Bio Active Protein and Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,065.40
      4,598.10
      6,130.80
      3,685.50
      5,528.25
      7,371.00
      605,280.00
      907,920.00
      1,210,560.00
      329,316.00
      493,974.00
      658,632.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report